ArticleCell death & disease2022

MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancer.

Yuanzhou Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.